Invesco Mutual FundEquity Schemes - Multi Cap Fund13.8 years
The fund seeks to generate long-term capital appreciation by investing in equity and equity-related securities of large, mid and small companies. The fund utilizes a bottom up investment approach to select stocks across the market capitalization range.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 4 Nov 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Prefer peers if · Prefer HSBC Multi Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.91% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Watch
Peak-to-trough -38.0%. Ask whether you can hold through a similar fall.
Vs category
Watch
45% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Deepak Gupta · 0.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 26.8% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 38%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
12 Jan 2018 – 20 Nov 2020
Trough 23 Mar 2020 · recovered in 242 days
-38.0%
23 Sept 2024 – open
Trough 30 Mar 2026 · not recovered
-22.6%
17 Jan 2022 – 2 Jun 2023
Trough 20 Jun 2022 · recovered in 347 days
-21.3%
6 Aug 2015 – 4 Jul 2016
Trough 26 Feb 2016 · recovered in 129 days
-19.5%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
22
Vs category
67
Consistency
49
Risk-adjusted
61
Drawdown
5
Mean
41
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 74 holdings · top 10 are 26.8%.
Zomato Ltd
Technology
4.3%
ICICI Bank Ltd
Financial
3.6%
Sai Life Sciences Ltd.
Healthcare
2.7%
Interglobe Aviation Ltd
Industrials
2.7%
Axis Bank Ltd
Financial
2.4%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
3 Nov 2026
DECISION
Status moved from MONITOR to REVIEW.
3 Nov 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
2 Nov 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
30 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
28 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
DECISION
Status moved from MONITOR to REVIEW.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
HSBC Mutual Fund
Kotak Mahindra Mutual Fund
WhiteOak Capital Mutual Fund
Axis Mutual Fund
Caveat: Higher TER
Groww Mutual Fund
Caveat: Higher TER
Invesco Mutual FundEquity Schemes - Multi Cap Fund13.8 years
The fund seeks to generate long-term capital appreciation by investing in equity and equity-related securities of large, mid and small companies. The fund utilizes a bottom up investment approach to select stocks across the market capitalization range.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 4 Nov 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Prefer peers if · Prefer HSBC Multi Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.91% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Watch
Peak-to-trough -38.0%. Ask whether you can hold through a similar fall.
Vs category
Watch
45% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Deepak Gupta · 0.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 26.8% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 38%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
4 Nov 2026 · +0.3% over 1Y
156.69
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
4 Nov 2026
-6.1%
12 Jan 2018 – 20 Nov 2020
Trough 23 Mar 2020 · recovered in 242 days
-38.0%
23 Sept 2024 – open
Trough 30 Mar 2026 · not recovered
-22.6%
17 Jan 2022 – 2 Jun 2023
Trough 20 Jun 2022 · recovered in 347 days
-21.3%
6 Aug 2015 – 4 Jul 2016
Trough 26 Feb 2016 · recovered in 129 days
-19.5%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
22
Vs category
67
Consistency
49
Risk-adjusted
61
Drawdown
5
Mean
41
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 74 holdings · top 10 are 26.8%.
Zomato Ltd
Technology
4.3%
ICICI Bank Ltd
Financial
3.6%
Sai Life Sciences Ltd.
Healthcare
2.7%
Interglobe Aviation Ltd
Industrials
2.7%
Axis Bank Ltd
Financial
2.4%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
3 Nov 2026
DECISION
Status moved from MONITOR to REVIEW.
3 Nov 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
2 Nov 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
30 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
28 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
DECISION
Status moved from MONITOR to REVIEW.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026